A bimetallic nanocomposite electrode for direct and rapid biosensing of p53 DNA plasmid

Abstract

A new label-free electrochemical DNA biosensor is presented based on carbon paste electrode (CPE) modified with gold (Au) and platinum (Pt) nanoparticles to prepare the bimetallic nanocomposite electrode. The proposed sensor was made by immobilization of 15-mer single stranded oligonucleotide probe related to p53 gene for detection of DNA plasmid samples. The hybridization detection relied on the alternation in the guanine oxidation signal following hybridization of the probe with complementary genomic DNA. The technique of differential pulse voltammetry (DPV) was used for monitoring guanine oxidation. To optimize the performance of the modified CPE, different electrodes were prepared in various percentages of Au and Pt nanoparticles. The modified electrode containing 15% Au/Pt bimetallic nanoparticles (15% Au/Pt-MCPE) was selected as the best working electrode. The selectivity of the sensor was investigated using plasmid samples containing non-complementary oligonucleotides. The detection limit of the biosensor was studied and calculated to be 53.10 pg μL −1 .

Therapeutic benefits of rutin and its nanoformulations

“…Using novel procedures to manipulate matter at an atomic or molecular level is known as nanotechnology that has gained wide application in all fields of sciences (Ahmadian et al, 2019; Dizaj, Lotfipour, Barzegar‐Jalali, Zarrintan, & Adibkia, 2016; Forouzideh et al, 2020; Hamidi‐Asl, Raoof, Naghizadeh, Sharifi, & Hejazi, 2015; Sharifi et al, 2019; Yazdani, Ahmadian, Sharifi, Shahi, & Dizaj, 2018). The development of drug delivery through nanoparticulate systems has a specified increase to technical novelty in the biomedicine area (Maleki Dizaj et al, 2019; Maleki Dizaj, Sharifi, & Jahangiri, 2019).…”

Recent Advances in Nanomaterials for Therapy and Diagnosis of Cardiovascular Disease

“…Nanotechnology, described as the study of materials at the atomic, molecular, and supramolecular levels, has shown promise in the field of CVDs. Nanotechnology is known as the application of nanotechnology to biological structures to prevent, identify, heal, or restore injured cells [3][4][5][6][7]. It is becoming increasingly important in the treatment of cardiovascular diseases.…”

The Application of Nanomaterials in Cardiovascular Diseases: A Review on Drugs and Devices

“…Nanotechnology, as the technology of materials on an atomic, molecular, and supramolecular scale, has shown promises for CVDs application. Nanotechnology is generally defined as the use of nanotechnology in preventing, diagnosing, curing disease or repairing damaged tissues in biological systems [3][4][5][6][7]. In recent years, by improving our understanding of diseases at the molecular level and the development of nanoscale technologies, nanorechnology has witnessed a growth explosion in the world.…”